Brokerages Set Regulus Therapeutics Inc. (NASDAQ:RGLS) Price Target at $8.50
Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) have been assigned a consensus rating of “Hold” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year […]
Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) have been assigned a consensus rating of “Hold” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year […]
